<DOC>
	<DOCNO>NCT02058888</DOCNO>
	<brief_summary>The worldwide increase incidence multidrug-resistant ( MDR ) pathogens alarm . Antimicrobial treatment risk factor isolation MDR pathogens therefore contribute observe trend . Differences degree selection pressure cause various antimicrobial systematically investigate today . The aim propose project determination impact antibiotic treatment copy number resistance gene human intestinal microbiome use metagenome shotgun sequence . The resistance gene count gastrointestinal tract determine clinical cohort patient treat either ciprofloxacin cotrimoxazol monotherapy . The subsequent quantification comparison selection pressure facilitate application antibiotic lower potential select resistance . To achieve goal , self-controlled , prospective observational epidemiological study perform two centre German Centre Infection Research ( Tübingen , Cologne ) .</brief_summary>
	<brief_title>Amplification Selection Antimicrobial Resistance Intestine</brief_title>
	<detailed_description />
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>male female patient ≥ 18 year patient acute leukaemia admission one 2 study centre obtain write consent treatment antibiotic previous 30 day pregnancy patient currently treat HIV and/or hepatitis b/c patient estimate scope consequence participation study patient likely able follow study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>metagenomics</keyword>
	<keyword>antimicrobial resistance</keyword>
	<keyword>multidrug resistance</keyword>
</DOC>